Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation

MLA

Rey, E., et al. Sofosbuvir Improves HCV-Induced Insulin Resistance by Blocking IRS1 Degradation. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3272..a25fba260731297ec8c351e4b567dc3c&authtype=sso&custid=ns315887.

APA

Rey, E., Ampuero Herrojo, J., Molina-Jiménez, F., García-García, Y., Muñoz Hernández, R., Romero Gómez, M., García-Monzón, C., Majano, P., & González-Rodríguez, A. (2021). Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation.

Chicago

Rey, E., Javier Ampuero Herrojo, F. Molina-Jiménez, Y. García-García, Rocío Muñoz Hernández, Manuel Romero Gómez, C. García-Monzón, P. Majano, and A. González-Rodríguez. 2021. “Sofosbuvir Improves HCV-Induced Insulin Resistance by Blocking IRS1 Degradation,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3272..a25fba260731297ec8c351e4b567dc3c&authtype=sso&custid=ns315887.